The FDA Fast-Tracks Another COVID-19 Booster While Preparing to Take Away Your Favorite Cold Medicine
The FDA does not use the same “safe and effective” standard on all its decisions, and the stench of political influence is hard to ignore.
As a medical doctor, I prescribed drugs, lots of drugs. I was taught (now I know indoctrinated) to view the Food and Drug Administration (FDA) as the gold standard of what medications were approved. They used objective science and were above politics and industry influence. I no longer believe this. I am not an anti-vaccine proponent and had my Pfizer vaccines in 2021 and every booster since.
Two FDA decisions have convinced me they play favorites and use different standards to evaluate drugs and vaccines. Recent declarations highlight the absurd and contradictory guidelines plaguing its approval process.
The New COVID-19 Booster
The latest booster was approved for everyone over six months of age, regardless of their vaccination status. Here is what their website said. “The FDA is confident in the safety and effectiveness of these updated vaccines and the agency’s benefit-risk assessment demonstrates that the benefits of these vaccines for individuals 6 months of age and older outweigh their risks.”
